Jens K. Habermann

University of Lübeck

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (10)

Arndt Peter Schulz

University of Lübeck

GERMANY

View details

Hidehiro Fukuyama

Professor

Kansai Medical University

JAPAN

View details

Tobias Lange

GERMANY

View details

Véronique Blanchard

GERMANY

View details

Silvère M van der Maarel

Leiden University Medical Center

NETHERLANDS

View details

Simon Eschweiler

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Timo Gemoll

University of Lübeck

GERMANY

View details

Mattias Collin

Lund University

SWEDEN

View details

Sarah Starzonek

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Oliver Stegle

Professor

Heidelberg University

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jens K. Habermann

Research Interests

Explore related searches

Contact this professor

Articles (10)

UNCAN.eu: Toward a European Federated Cancer Research Data Hub.

Panomics reveals patient individuality as the major driver of colorectal cancer progression.

Tumor cell E-selectin ligands determine partial inhibitory efficacy of bortezomib on spontaneous lung metastasis formation of solid human tumors in vivo

Protein Expression of AEBP1, MCM4, and FABP4 Differentiate Osteogenic, Adipogenic, and Mesenchymal Stromal Stem Cells

SATB1, genomic instability and Gleason grading constitute a novel risk score for prostate cancer.

Correction: Gemoll et al. Protein Profiling of Serum Extracellular Vesicles Reveals Qualitative and Quantitative Differences after Differential Ultracentrifugation and ExoQuick™ Isolation. <i>J. Clin. Med.</i> 2020, <i>9</i>, 1429.

Single Cell Genetic Profiling of Tumors of Breast Cancer Patients Aged 50 Years and Older Reveals Enormous Intratumor Heterogeneity Independent of Individual Prognosis.

Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies.

IgG Fc sialylation is regulated during the germinal center reaction upon immunization with different adjuvants

Genome Instability Profiles Predict Disease Outcome in a Cohort of 4,003 Patients with Breast Cancer.

Collaborators (10)

Arndt Peter Schulz

Hidehiro Fukuyama

Tobias Lange

Véronique Blanchard

Silvère M van der Maarel

Simon Eschweiler

Timo Gemoll

Mattias Collin

Sarah Starzonek

Oliver Stegle

Make your next move.